The effects of macrophage migratory inhibitory factor on acute-phase protein production in primary human hepatocytes

International Journal of Molecular Medicine

Volumn 18, Issue 5, 2006, Pages 957-961

  Wheelhouse, Nicholas M ^a   Dowidar, Nabil ^a   Dejong, Cornelis H C ^a   Garden, O James ^a   Powell, James J ^a   Barber, Matthew D ^a   Sangster, Kathryn ^a   Maingay, Jean P ^a   Ross, James A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acute phase protein response; C reactive protein; Dexamethasone; Hepatocyte; Human; Macrophage migration inhibitory factor

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; DEXAMETHASONE; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; RECOMBINANT PROTEIN;

ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; HEPATITIS; HUMAN; LIVER CELL; METABOLISM;

ACUTE-PHASE PROTEINS; ALPHA 1-ANTICHYMOTRYPSIN; C-REACTIVE PROTEIN; DEXAMETHASONE; HEPATITIS; HEPATOCYTES; HUMANS; INTERLEUKIN-6; MACROPHAGE MIGRATION-INHIBITORY FACTORS; RECOMBINANT PROTEINS;

EID: 36148966750     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.5.957     Document Type: Article

References (24)

1. Takahashi M, Nishihara J, Shimpo M, Mizue Y, Ueno S, Mano H, Kobayashi E, Ikeda and Shimada K: Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 52: 438-445, 2001. (Pubitemid 33153106)
2. Bacher M, Schrader J, Thompson N, Kuschela K, Gemsa D, Waeber G and Sclegel J: Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycaemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am J Pathol 162: 11-17, 2003. (Pubitemid 36041985)
3. Tierney T, Patel R, Stead CA, Leng L, Bucala R and Buckingham JC: Macrophage migration inhibitory factor is released from pituitary follico-stellate-like cells by endotoxin and dexamethasone and attenuates the steroid-induced inhibition of interleukin 6 release. Endocrinology 146: 35-43, 2005. (Pubitemid 40051720)
4. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A and Bucala R: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759, 1993. (Erratum Nature 378: 419, 1995).
5. Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, Calandra T, Gemsa D, Donnelly T, Atkins RC and Bucala R: Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 150: 235-246, 1997.
6. Roger T, David J, Glauser MP and Calandra T: MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924, 2001.
7. Koebernick H, Grode L, David JR, Rohde W, Rolph MS, Mittrucker H-W and Kaufmann HE: Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc Natl Acad Sci USA 99: 13681-13686, 2002.
8. Calandra T, Spigel LA, Metz CN and Bucala R: Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA 95: 11383-11388, 1998.
9. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, Bruce LJ and Bucala R: Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3: 320-323, 1997.
10. Santos L, Hall P, Metz C, Bucala R and Morand EF: Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 123: 309-314, 2001. (Pubitemid 32174784)
11. Akbar SM, Abe M, Murakami H, Tanimoto K, Kumagi T, Yamashita Y, Michitaka K, Horiike N and Onji M: Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis. Cancer Lett 171: 125-132, 2001.
12. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R and Glauser MP: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6: 164-170, 2000. (Pubitemid 30082360)
13. Lehmann LE, Novender U, Schroeder S, Pietsch T, von Spiegel T, Putensen C, Hoeft A and Stuber F: Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 27: 1412-1415, 2001.
14. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A and Bucala R: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 37: 68-71, 1995.
15. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T and Bucala R: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93: 7849-7854, 1996. (Pubitemid 26277127)
16. O'Riordain MG, Ross JA, Fearon KCH, Maingay J, Farouk M, Garden OJ and Carter DC: Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol 269: E323-E330, 1995.
17. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R and Heinrich PC: Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12: 1179-1186, 1990.
18. Wigmore SJ, Fearon KCH, Maingay JP, Lai PBS and Ross JA: Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 273: E720-E726, 1997.
19. Black S, Kushner I and Samols D: C-reactive protein. J Biol Chem 279: 48487-48490, 2004.
20. Skeel A and Leonard EJ: Alpha-1-Antichymotrypsin is the human plasma inhibitor of macrophage ectoenzymes that cleave pro-macrophage stimulating protein. J Biol Chem 276: 21932-21937, 2001.
21. Hack CE, De Groot ER, Felt-Bersma RJ, Strack Van Schijndel RJ, Nuijens JH, Eerenberg-Belmer AJ, Thijs LG and Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704-1710, 1989.
22. Heinrich PC, Castell JV and Andus T: Interleukin-6 and the acute phase response. Biochem J 265: 621-636, 1990.
23. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH and Scholmerich J: Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101: 782-785, 1991.
24. Sheldon J, Riches P, Gooding R, Soni N and Hobbs JR: C-reactive protein and its cytokine mediators in intensive-care patients. Clin Chem 39: 147-150, 1993.